DURECT Corporation (DRRX) Social Stream
DURECT CORP (DRRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering DURECT CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 3 | $7 | $6 | $6.25 | $0.606 | 931.35% |
| 2021-12-23 | 2 | $6 | $6 | $6 | $0.606 | 890.1% |
| 2022-05-05 | 2 | $6 | $5 | $5.666 | $0.606 | 834.98% |
| 2022-08-05 | 3 | $6 | $5 | $5.666 | $0.606 | 834.98% |
| 2022-11-03 | 3 | $6 | $4 | $5.333 | $0.606 | 780.03% |
| 2022-12-07 | 3 | $40 | $32 | $35.666 | $0.606 | 5785.48% |
| 2022-12-16 | 2 | $37 | $32 | $34.666 | $0.606 | 5620.46% |
| 2023-03-08 | 3 | $37 | $32 | $34.666 | $0.606 | 5620.46% |
| 2023-05-09 | 3 | $44 | $32 | $36 | $0.606 | 5840.59% |
| 2023-08-10 | 3 | $41 | $27 | $33.333 | $0.606 | 5400.5% |
| 2023-10-16 | 4 | $41 | $12 | $28 | $0.606 | 4520.46% |
| 2023-11-08 | 4 | $41 | $5 | $18.166 | $0.606 | 2897.69% |
| 2023-11-14 | 3 | $8.5 | $5 | $6.75 | $0.606 | 1013.86% |
The Trend in the Analyst Price Target
Over the past 16 months, DRRX's average price target has gone up $1.42.
Over the past 36 weeks, DRRX's average upside potential has been 1,091.01%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-08-10 | 3 | 44.0 | 27 | 34.333 | 3.250 | 956.4% |
| 2023-09-14 | 4 | 41.0 | 12 | 28.000 | 2.950 | 849.15% |
| 2023-10-16 | 4 | 41.0 | 12 | 28.000 | 2.670 | 948.69% |
| 2023-11-08 | 4 | 41.0 | 5 | 18.166 | 0.527 | 3347.06% |
| 2023-11-14 | 3 | 8.5 | 5 | 6.750 | 0.544 | 1140.81% |
DRRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 18 months, DRRX's average broker recommendation rating worsened by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DRRX as an investment opportunity.
- In terms of how DURECT CORP fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1574% of that group.
- In terms of how DURECT CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than 115.97% of that group.
- DRRX has a lower variance in analysts' estimates than -272.62% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, DURECT CORP's average analyst price target is greater than 781.71% of them.
Stocks similar to DURECT CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NWBO, LXRX, and CBAY.
View All Top Stocks by Price Target
What is the outlook for DRRX? Use POWR Ratings for clearer insight into price direction.